{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:00:28Z","timestamp":1789754428740,"version":"4.0.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.mce.2012.10.029","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T22:02:06Z","timestamp":1355954526000},"page":"91-97","source":"Crossref","is-referenced-by-count":84,"title":["Longterm management of Polycystic Ovarian Syndrome (PCOS)"],"prefix":"10.1016","volume":"373","author":[{"given":"Gordon W.","family":"Bates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Legro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2012.10.029_b0005","doi-asserted-by":"crossref","unstructured":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):854\u201365.","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"10.1016\/j.mce.2012.10.029_b0010","series-title":"2009 PtOSOS Textbook of Cancer Epidemiology","author":"Adami","year":"2008"},{"issue":"2","key":"10.1016\/j.mce.2012.10.029_b0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2009-1985","article-title":"Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial","volume":"95","author":"Agarwal","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.mce.2012.10.029_b0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0026-0495(95)90118-3","article-title":"Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome","volume":"44","author":"Andersen","year":"1995","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.mce.2012.10.029_b0025","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.psyneuen.2008.12.001","article-title":"Disturbed stress responses in women with polycystic ovary syndrome","volume":"34","author":"Benson","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"23","key":"10.1016\/j.mce.2012.10.029_b0030","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","article-title":"Body-mass index and mortality among 1.46 million white adults","volume":"363","author":"Berrington de Gonzalez","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.mce.2012.10.029_b0035","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1104119","article-title":"General and abdominal obesity and risk of death among black women","volume":"365","author":"Boggs","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.mce.2012.10.029_b0040","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.fertnstert.2011.09.002","article-title":"The phenotype of polycystic ovary syndrome ameliorates with aging","volume":"96","author":"Brown","year":"2011","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.mce.2012.10.029_b0045","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta- cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"issue":"2 Pt 1","key":"10.1016\/j.mce.2012.10.029_b0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AOG.0b013e31823f7135","article-title":"A 20-year follow-up of young women with polycystic ovary syndrome","volume":"119","author":"Carmina","year":"2012","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.mce.2012.10.029_b0055","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ijc.25717","article-title":"Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study","volume":"129","author":"Chang","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0065","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1472-6483(10)60175-7","article-title":"Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review","volume":"19","author":"Chittenden","year":"2009","journal-title":"Reprod. Biomed. Online."},{"issue":"10","key":"10.1016\/j.mce.2012.10.029_b0070","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/oxfordjournals.humrep.a135772","article-title":"Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women","volume":"10","author":"Clark","year":"1995","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.mce.2012.10.029_b0075","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/humrep\/13.6.1502","article-title":"Weight loss in obese infertile women results in improvement in reproductive outcomes for all forms of fertility treatment","volume":"13","author":"Clark","year":"1998","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.mce.2012.10.029_b0080","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.mce.2012.10.029_b0085","first-page":"403","article-title":"Chronic anovulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2011.10.009","article-title":"The epidemiology of endometrial and ovarian cancer","volume":"26","author":"Cramer","year":"2012","journal-title":"Hematol. Oncol. Clin. North. Am."},{"issue":"9","key":"10.1016\/j.mce.2012.10.029_b0095","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","article-title":"Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet","volume":"18","author":"Crosignani","year":"2003","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.mce.2012.10.029_b0100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.mce.2012.10.029_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2710.2011.01280.x","article-title":"Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes","volume":"37","author":"Derosa","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/AOG.0b013e318202b0a4","article-title":"Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"117","author":"Dokras","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.mce.2012.10.029_b0125","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS consensus workshop group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7326\/0003-4819-153-3-201008030-00005","article-title":"Weight and metabolic outcomes after 2years on a low-carbohydrate versus low-fat diet: a randomized trial","volume":"153","author":"Foster","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.mce.2012.10.029_b0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs. levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.mce.2012.10.029_b0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3945\/ajcn.111.024927","article-title":"Two-year sustained weight loss an dmetabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study","volume":"95","author":"Garvey","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mce.2012.10.029_b0150","article-title":"Age associated differences in prevalence of individual rotterdam criteria and metabolic risk factors during reproductive age in 446 Caucasian women with polycystic ovary syndrome","author":"Glintborg","year":"2012","journal-title":"Horm. Metab. Res"},{"issue":"2","key":"10.1016\/j.mce.2012.10.029_b0155","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20\u201324years, continuing through 32\u201341years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.AOG.0000104485.44999.C6","article-title":"Polycystic ovary syndrome","volume":"103","author":"Guzick","year":"2004","journal-title":"Obstet. Gynecol."},{"issue":"9793","key":"10.1016\/j.mce.2012.10.029_b0165","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0140-6736(11)60812-X","article-title":"Quantification of the effect of energy imbalance on bodyweight","volume":"378","author":"Hall","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mce.2012.10.029_b0170","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1634\/theoncologist.2009-0300","article-title":"Risk of cancer following hospitalization for type 2 diabetes","volume":"15","author":"Hemminki","year":"2010","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.mce.2012.10.029_b0175","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/oxfordjournals.humrep.a019512","article-title":"Effects of weight loss on the hormonal profile in obese, infertile women","volume":"11","author":"Hollmann","year":"1996","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"10.1016\/j.mce.2012.10.029_b0185","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1210\/jc.83.9.3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.mce.2012.10.029_b0190","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of type 2 diabetes with troglitazone in the diabetes prevention program","volume":"54","author":"Knowler","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0195","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1067\/mob.2001.109596","article-title":"Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study","volume":"184","author":"Korhonen","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0200","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.fertnstert.2010.12.002","article-title":"The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.mce.2012.10.029_b0210","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0215","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.mce.2012.10.029_b0220","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","author":"Legro","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.mce.2012.10.029_b0225","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.mce.2012.10.029_b0230","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","author":"Legro","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.mce.2012.10.029_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2010.12.093","article-title":"Longitudinal evaluation of cancer- associated biomarkers before and after weight loss in RENEW study participants: Implications for cancer risk reduction","author":"Linkov","year":"2011","journal-title":"Gynecol. Oncol"},{"issue":"10","key":"10.1016\/j.mce.2012.10.029_b0240","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","article-title":"The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.mce.2012.10.029_b0245","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.fertnstert.2011.07.1100","article-title":"The effect of increasing obesity on the response to and outcome of assisted reproductive technology: a national study","volume":"96","author":"Luke","year":"2011","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.mce.2012.10.029_b0250","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the androgen excess and polycystic ovary syndrome society","volume":"92","author":"Moran","year":"2009","journal-title":"Fertil. Steril."},{"issue":"7","key":"10.1016\/j.mce.2012.10.029_b0255","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.mce.2012.10.029_b0260","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2012.10.029_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleep.2012.07.002","article-title":"Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome","author":"Nandalike","year":"2012","journal-title":"Sleep Med."},{"issue":"9","key":"10.1016\/j.mce.2012.10.029_b0270","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","author":"Norman","year":"2001","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.mce.2012.10.029_b0275","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-142-8-200504190-00009","article-title":"The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial","volume":"142","author":"Orchard","year":"2005","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0280","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dem391","article-title":"Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study","volume":"23","author":"Palomba","year":"2008","journal-title":"Hum. Reprod."},{"issue":"11","key":"10.1016\/j.mce.2012.10.029_b0285","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/humrep\/deq254","article-title":"Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0290","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1464-5491.2004.01395.x","article-title":"Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity","volume":"22","author":"Park","year":"2005","journal-title":"Diabet. Med."},{"issue":"4","key":"10.1016\/j.mce.2012.10.029_b0295","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2265.2010.03956.x","article-title":"PCOS Forum: research in polycystic ovary syndrome today and tomorrow","volume":"74","author":"Pasquali","year":"2011","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"5","key":"10.1016\/j.mce.2012.10.029_b0300","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/0884533611419859","article-title":"Nutraceutical supplements for weight loss a systematic review","volume":"26","author":"Poddar","year":"2011","journal-title":"Nutr. Clin. Pract."},{"issue":"4","key":"10.1016\/j.mce.2012.10.029_b0305","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/annonc\/mdq464","article-title":"Metabolic syndrome and endometrial cancer risk","volume":"22","author":"Rosato","year":"2011","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.mce.2012.10.029_b0315","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/gme.0b013e3182113672","article-title":"Timing of hormone therapy, type of menopause, and coronary disease in women: data from the national heart, lung, and blood institute-sponsored women\u2019s ischemia syndrome evaluation","volume":"18","author":"Shufelt","year":"2011","journal-title":"Menopause"},{"issue":"19","key":"10.1016\/j.mce.2012.10.029_b0320","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.286.19.2421","article-title":"Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus","volume":"286","author":"Solomon","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mce.2012.10.029_b0325","doi-asserted-by":"crossref","first-page":"E576","DOI":"10.1152\/ajpendo.00725.2007","article-title":"Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth?","volume":"294","author":"Sverrisdottir","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.mce.2012.10.029_b0330","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.mce.2012.10.029_b0340","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1093\/humrep\/der101","article-title":"Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome","volume":"26","author":"Taylor","year":"2011","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.mce.2012.10.029_b0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/AOG.0b013e31820209bb","article-title":"Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia","volume":"117","author":"Wang","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.mce.2012.10.029_b0350","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9438","key":"10.1016\/j.mce.2012.10.029_b0355","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case \u2013 control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720712004819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720712004819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T23:53:57Z","timestamp":1539993237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720712004819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":70,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0303720712004819"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2012.10.029","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}